Cardiovascular diseases

6 April 2022
26 March 2025

Cardiovascular diseases

Open Access

Trends in dual antiplatelet therapy regimens and clinical outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention with drug-eluting stents: A multicenter real-world study

Trends in dual antiplatelet therapy regimens and clinical outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention with drug-eluting stents: A multicenter real-world study

Patient selection flow diagram. Flowchart illustrating the inclusion and exclusion criteria for patients receiving a diagnosis of acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) and receiving dual antiplatelet therapy (DAPT).

Open Access

Efficacy and safety of different dual antiplatelet strategies in patients undergoing percutaneous coronary intervention: A systematic review and network meta-analysis

Efficacy and safety of different dual antiplatelet strategies in patients undergoing percutaneous coronary intervention: A systematic review and network meta-analysis

Efficacy and safety of different dual antiplatelet strategies in patients undergoing percutaneous coronary intervention: a systematic review and network meta-analysis. The illustration provides a comparative analysis of different dual antiplatelet strategies in terms of their efficacy and safety. ASA, aspirin; CI, confidence interval; DAPT, dual antiplatelet therapy; RR, risk ratios.

Open Access

Fruit and vegetable intake and the risk of arterial hypertension in China: A prospective cohort study

Fruit and vegetable intake and the risk of arterial hypertension in China: A prospective cohort study

Restricted cubic spline curves of the association between total fruit and vegetable (TFV) consumption and risk of incident hypertension. Adjusted for age (continuous), sex (male or female), residence (urban or rural), region (south or north), education level (less than high school or not), body mass index (continuous), family history of hypertension (yes or no), legume consumption (≥125 g/day or not), red meat consumption (≥75 g/day or not), fish consumption (≥200 g/week or not), smoking status (current, former, never), current drinker (yes or no), cohort sources, physical activity (quartiles), diabetes (yes or no), hypercholesterolemia (yes or no), and high-normal blood pressure (yes or no). With the exception of TFV intake, models also mutually adjusted for fruit intake and vegetable intake. Solid lines represented point estimates of the hazard ratios (HRs) and dashed lines represented 95% confidence intervals (CIs).

Open Access

A superficial siderosis-related transient focal neurological episode in a patient with Marfan syndrome

A superficial siderosis-related transient focal neurological episode in a patient with Marfan syndrome

Sagittal computed tomography of lumbal spine showing dural ectasia and Tarlow Cyst (red arrows) (A). Magnetic resonance imaging (MRI) axial slice, susceptibility-weighted imaging (SWI) sequences showing siderosis in cerebellar sulci (red arrows) and in the inset uncharacteristic iron deposition in dental nuclei, more pronounced on the left side (red arrows) (B, inset). MRI, SWI, axial slice, showing numerous foci of superficial siderosis (C).

Open Access

Pharmacotherapy treatment patterns at hospital discharge and clinical outcomes among patients with heart failure with reduced ejection fraction

Pharmacotherapy treatment patterns at hospital discharge and clinical outcomes among patients with heart failure with reduced ejection fraction

Discharge medication profiles in the overall cohort. (A) Standard medication profiles at discharge and (B) pharmacotherapy treatment patterns for heart failure with reduced ejection fraction at discharge.

Open Access

Countrywide cardiovascular disease prevention and control in 49 countries with different socio-economic status

Countrywide cardiovascular disease prevention and control in 49 countries with different socio-economic status

Age-standardized cardiovascular disease mortality rate per 100,000 population in countries with different levels of socioeconomic development, both sexes, 2000–2016.